Related Experiment Video
Updated: Jun 27, 2026
05:55
Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Complement in multiple sclerosis: its role in disease and potential as a biomarker
G Ingram1, S Hakobyan, N P Robertson
1Department of Neurosciences, Cardiff University, Heath Park, Cardiff, UK.
Clinical and Experimental Immunology
|December 2, 2008
Summary
This review explores the role of complement activation in multiple sclerosis (MS) pathogenesis. Evidence suggests complement involvement, highlighting potential biomarkers and therapeutic targets for this central nervous system inflammatory disease.
Area of Science:
- Neuroimmunology
- Inflammatory Diseases
- Complement System Biology
Background:
- Multiple sclerosis (MS) is a complex central nervous system inflammatory disease with unclear immunopathogenesis.
- Persistent inflammation in MS suggests involvement beyond initial T cell activation.
- Complement activation products are found in MS tissues, but its precise role remains elusive.
Purpose of the Study:
- To review evidence implicating complement activation in MS.
- To evaluate complement components and regulators as potential MS biomarkers.
- To identify future research directions for complement in MS.
Main Methods:
- Review of pathological studies in MS.
- Analysis of animal models of MS.
- Examination of human functional and genetic studies related to complement.
Main Results:
- Pathological and functional data support complement system involvement in MS.
- Genetic variations in complement regulators may influence autoimmune disorders.
- The exact contribution of complement to MS phenotype and outcome requires further investigation.
Conclusions:
- Complement activation is implicated in the pathogenesis of multiple sclerosis.
- Complement components and their polymorphic variants may serve as disease biomarkers.
- Further research is needed to elucidate the full impact of the complement system in MS.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...